Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 5.74 EUR -1.03% Market Closed
Market Cap: 160.7m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Hyloris Pharmaceuticals SA
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyloris Pharmaceuticals SA
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Hyloris Pharmaceuticals SA
XBRU:HYL
Tax Provision
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ucb SA
XBRU:UCB
Tax Provision
-€98m
CAGR 3-Years
6%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Financiere de Tubize SA
XBRU:TUB
Tax Provision
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hyloris Pharmaceuticals SA
Glance View

Market Cap
160.7m EUR
Industry
Pharmaceuticals

Hyloris Pharmaceuticals SA engages in the development and reformulating of pharmaceutical products. The company is headquartered in Liege, Liege and currently employs 14 full-time employees. The company went IPO on 2020-06-29. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.

HYL Intrinsic Value
4.38 EUR
Overvaluation 24%
Intrinsic Value
Price

See Also

What is Hyloris Pharmaceuticals SA's Tax Provision?
Tax Provision
0 EUR

Based on the financial report for Dec 31, 2023, Hyloris Pharmaceuticals SA's Tax Provision amounts to 0 EUR.

Back to Top